Inhibrx Biosciences Inc (INBX)
Cost of Revenue
$0.00
Quarterly · Period ending: · USD
INBX Cost of Revenue
Latest reported$0.00period ending
Latest reported$0.00period ending
INBX Quarterly Cost of Revenue ($7.29M → $0.00)
Quarterly cost of revenue
High-resolution chart · PNG
INBX cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 0 | |
| 537,000 | |
| 564,000 | |
| 582,000 | |
| 662,000 | |
| 675,000 | |
| 689,000 | |
| 760,000 | |
| 0 | |
| 360,000 | |
| 298,000 | |
| 304,000 | |
| 295,000 | |
| 294,000 | |
| 720,000 | |
| 719,000 | |
| 708,000 | |
| 699,000 | |
| 692,000 | |
| 676,000 | |
| 0 | |
| 16,438,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 4,000 | |
| 506,000 | |
| 12,174,000 | |
| 10,665,000 | |
| 4,680,000 | |
| 8,495,000 | |
| 10,779,000 | |
| 7,289,000 |